These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 35347946

  • 21. Daily low-dose prednisolone to prevent relapse of steroid-sensitive nephrotic syndrome in children with an upper respiratory tract infection: PREDNOS2 RCT.
    Christian MT, Webb NJ, Woolley RL, Afentou N, Mehta S, Frew E, Brettell EA, Khan AR, Milford DV, Bockenhauer D, Saleem MA, Hall AS, Koziell A, Maxwell H, Hegde S, Finlay ER, Gilbert RD, Jones C, McKeever K, Cook W, Ives N.
    Health Technol Assess; 2022 Jan; 26(3):1-94. PubMed ID: 35060851
    [Abstract] [Full Text] [Related]

  • 22. [Clinical comprehensive evaluation of Shexiang Tongxin Dropping Pills].
    Tian X, Zhu H, Li W, Han S.
    Zhongguo Zhong Yao Za Zhi; 2024 Feb; 49(4):1122-1128. PubMed ID: 38621919
    [Abstract] [Full Text] [Related]

  • 23. Exploration of the utility of different doses of Qingfei Dayuan granules: a multicenter, randomized, double-blind, placebo-controlled trial.
    Zhu X, Li W, Yang Y, Li H, Yang M, Zhang J, Li X, Yan G, Wu X, Zhao W, Cui M, Yang X, Hu X, Huang J, Ba Y.
    Aging (Albany NY); 2024 Feb 26; 16(5):4503-4517. PubMed ID: 38412322
    [Abstract] [Full Text] [Related]

  • 24. [A multiple center, randomized, controlled, double-blinded and double-dummy trial of Yiqing Shuangjie Capsule and Tablet in treating acute upper respiratory tract infection with the syndrome of heat attacking the lung and Weifen].
    Wang L, Zhang RM, Zhao YL, Feng GX, Pan DJ, Huang XY, Li TQ.
    Zhong Xi Yi Jie He Xue Bao; 2008 Feb 26; 6(2):139-47. PubMed ID: 18241647
    [Abstract] [Full Text] [Related]

  • 25. [Extraction process optimization and link evaluation of Reyanning Mixture based on quality by design idea].
    Zhang Y, Qiu JQ, Wei X, Lei X, Tang YY, Qu Q, Zhao XM, Zhang XB, Sun J, Luo W, Song X.
    Zhongguo Zhong Yao Za Zhi; 2024 Jun 26; 49(12):3229-3241. PubMed ID: 39041084
    [Abstract] [Full Text] [Related]

  • 26. Efficacy and safety of Reyanning mixture combined with conventional Western medicine for treating COVID-19: A protocol for systematic review and meta-analysis.
    Li Y, Zhang J, Li S, Li F, Zhao C, Li F, Wang W, Wang W.
    Medicine (Baltimore); 2021 Jan 22; 100(3):e24169. PubMed ID: 33546032
    [Abstract] [Full Text] [Related]

  • 27. [Clinical application evaluation and revision suggestions of clinical practice guideline on traditional Chinese medicine therapy alone or combined with antibiotics for upper respiratory tract infection in children].
    Liu QH, Rong P, Wang M, Zhang BL, Xie YM, Zhang JH, Yan HH, Li RB, Li L, Zhang XL, Ma R.
    Zhongguo Zhong Yao Za Zhi; 2018 Dec 22; 43(24):4753-4758. PubMed ID: 30717514
    [Abstract] [Full Text] [Related]

  • 28. [Systematic evaluation and Meta-analysis on effectiveness and safety of Yupingfeng Granules on recurrent respiratory tract infection].
    Zhang LD, Lyu J, Xie YM, Sun MH.
    Zhongguo Zhong Yao Za Zhi; 2019 Oct 22; 44(20):4379-4386. PubMed ID: 31872622
    [Abstract] [Full Text] [Related]

  • 29. The future of Cochrane Neonatal.
    Soll RF, Ovelman C, McGuire W.
    Early Hum Dev; 2020 Nov 22; 150():105191. PubMed ID: 33036834
    [Abstract] [Full Text] [Related]

  • 30. [Suggestions on design of evidence-based traditional Chinese medicine clinical study for new public health emergencies].
    Wang LX, Xie YM.
    Zhongguo Zhong Yao Za Zhi; 2020 May 22; 45(10):2291-2295. PubMed ID: 32495582
    [Abstract] [Full Text] [Related]

  • 31. [Post-marketing pharmaco-economics evaluation of Jinye Baidu Granules].
    Liu H, Han S, Xie YM, Yu YS, Jiang JJ.
    Zhongguo Zhong Yao Za Zhi; 2020 Aug 22; 45(15):3497-3504. PubMed ID: 32893536
    [Abstract] [Full Text] [Related]

  • 32. [Clinical application evaluation of clinical practice guideline on traditional Chinese medicine therapy alone or combined with antibiotics for uncomplicated lower urinary tract infection].
    Yu GY, Xie YM, Gao N, Sun Y, Miao RP, Han SJ, Yang HW, Xiong M, Liu H, Liao X, Wang YX, Su XN, Xu XF, Wang LF, Li YL, Zhang JH, Zhang BL.
    Zhongguo Zhong Yao Za Zhi; 2018 Dec 22; 43(24):4746-4752. PubMed ID: 30717513
    [Abstract] [Full Text] [Related]

  • 33. [Three oral Chinese patent medicines for children with tic disorder: a rapid health technology assessment].
    Wu X, Wang Z, Liao X, Wang YY.
    Zhongguo Zhong Yao Za Zhi; 2023 Jul 22; 48(14):3965-3976. PubMed ID: 37475087
    [Abstract] [Full Text] [Related]

  • 34. [Cost-effectiveness analysis of Chaiyin Granules in treatment of influenza].
    Ding LM, Yang DW, Zhang HC, Ma X, Yan ZG, Zhang ST, Ma WZ, Li WG, Wu DX, Jiang QR.
    Zhongguo Zhong Yao Za Zhi; 2023 Aug 22; 48(16):4529-4535. PubMed ID: 37802879
    [Abstract] [Full Text] [Related]

  • 35. [Report standards for clinical comprehensive evaluation of Chinese patent medicine].
    Zhang Q, Wang ZF, Xie YM, Li YY, Wang LX, Liu H, Geng HJ, Cui X, Liu FM, Sun CQ, Wei RL, Zhang LD.
    Zhongguo Zhong Yao Za Zhi; 2021 Dec 22; 46(23):6062-6067. PubMed ID: 34951233
    [Abstract] [Full Text] [Related]

  • 36. [Key points of post-marketing evaluation of classic traditional Chinese medicine prescriptions based on combination of disease and syndrome].
    Wang XL, Zhu MJ, Wang JR, Li B, Yu R, Peng GC, Zhao QF, Wang YX.
    Zhongguo Zhong Yao Za Zhi; 2021 Apr 22; 46(8):2004-2009. PubMed ID: 33982512
    [Abstract] [Full Text] [Related]

  • 37. [Chinese medicine for acute upper respiratory tract infection: a systematic review of randomized controlled trials].
    Zhang WB, Jiang HL, Zhou W, Zhong YQ, Yang HM, Fu JJ, Mao B.
    Zhong Xi Yi Jie He Xue Bao; 2009 Aug 22; 7(8):706-16. PubMed ID: 19671407
    [Abstract] [Full Text] [Related]

  • 38. [Advantages and disadvantages of production quality of Fufang Danshen Prescription based on high-quality Chinese patent medicine evaluation criteria].
    Zhao AY, Liu YP, Chen S, Guo C, Liu YZ, Wang ZG, Liu Y, Liu A.
    Zhongguo Zhong Yao Za Zhi; 2022 Sep 22; 47(17):4814-4822. PubMed ID: 36164888
    [Abstract] [Full Text] [Related]

  • 39. [Multi-criteria decision analysis in clinical comprehensive evaluation of Chinese patent medicine].
    Dai ZQ, Xu SM, Wu X, Li MM, Hu J, Liao X.
    Zhongguo Zhong Yao Za Zhi; 2022 Jun 22; 47(12):3155-3160. PubMed ID: 35851106
    [Abstract] [Full Text] [Related]

  • 40.
    Desser AS, Arentz-Hansen H, Fagerlund BF, Harboe I, Lauvrak V.
    ; 2017 08 25. PubMed ID: 29553663
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.